| George Henry Dugas, RPH | |
|
105 N Cities Service Hwy, Sulphur, LA 70663-5419 | |
| (337) 533-1137 | |
| (337) 533-9879 |
| Full Name | George Henry Dugas |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 105 N Cities Service Hwy, Sulphur, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891000717 | NPI | - | NPPES |
| 9192 | Other | LA | LOUISIANA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 9192 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| George Henry Dugas, RPH 105 N Cities Service Hwy, Sulphur, LA 70663-5419 Ph: (337) 533-1137 | George Henry Dugas, RPH 105 N Cities Service Hwy, Sulphur, LA 70663-5419 Ph: (337) 533-1137 |
News Archive
Anacor Pharmaceuticals announced today that the University of California San Francisco (UCSF) has been awarded $718,136 in funding from the National Institutes of Health (NIH) to discover and optimize novel oxaboroles as antimalarial drugs in collaboration with Anacor Pharmaceuticals. The NIH grant provides support for the period beginning September 30, 2011 and ending September 29, 2012.
Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.
Scientists are keeping their eye on a new discovery published in the November 2011 print issue of the FASEB Journal (http://www.fasebj.org) that explains what causes some genes to go out of control. Scientists have identified a "cellular switch," called eye transformer, that controls the flow of information from chemical signals outside of the cell to genes in the cell nucleus.
RetroSense Therapeutics, LLC, a Wayne State University start-up biotechnology company, has received the Luis Villalobos Award from the Angel Capital Association, the world's leading professional association for angel investors.
A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.
› Verified 7 days ago
Alexandra Porter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1421 Beglis Pkwy, Sulphur, LA 70663 Phone: 337-528-9918 | |
Mrs. Juanita Tarver Gilbert, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 195 Sam Dunham Rd, Sulphur, LA 70663 Phone: 337-526-3158 | |
Mr. Si Cong Van, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1021 Beglis Pkwy, Sulphur, LA 70663 Phone: 337-527-6575 | |
Scott R Darbonne, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1021 Beglis Pkwy, Sulphur, LA 70663 Phone: 337-527-6575 | |
D'undria Taylor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1508 Beglis Pkwy, Sulphur, LA 70663 Phone: 337-625-2660 | |
Dr. Larry Dale Collins Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3901 Maplewood Dr, Sulphur, LA 70663 Phone: 337-287-9599 | |
Marla Karr Bourgeois, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1021 Beglis Pkwy, Sulphur, LA 70663 Phone: 337-527-6575 |